Álvaro
López Janeiro
Colaborador Clínico
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublications en collaboration avec des chercheurs de David Geffen School of Medicine at UCLA (1)
2023
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378